These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2721031)

  • 21. Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats.
    Nuglozeh E; Gauquelin G; Garcia R; Tremblay J; Schiffrin EL
    Am J Physiol; 1990 Jul; 259(1 Pt 2):F130-7. PubMed ID: 2165357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exaggerated natriuresis in transgenic (mRen2)27 rats.
    Schneider K; Gross V; Lippoldt A; Luft FC
    J Hypertens; 1997 Sep; 15(9):1041-8. PubMed ID: 9321753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered regulation of renal sodium transporters and natriuretic peptide system in DOCA-salt hypertensive rats.
    Bae EH; Kim IJ; Ma SK; Kim SW
    Regul Pept; 2009 Oct; 157(1-3):76-83. PubMed ID: 19422859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
    Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
    J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac hypertrophy and brain natriuretic peptide in experimental hypertension.
    Kohno M; Fukui T; Horio T; Yokokawa K; Yasunari K; Yoshiyama M; Kurihara N; Takeda T
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R451-7. PubMed ID: 8141402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natriuretic and antihypertensive effects of potassium in DOCA-salt hypertensive rats.
    Fujita T; Sato Y
    Kidney Int; 1983 Dec; 24(6):731-9. PubMed ID: 6325798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of renal sympathetic activity with potassium supplement in DOCA-salt rats.
    Sato Y; Fujita T
    Jpn Heart J; 1984 Mar; 25(2):253-61. PubMed ID: 6748225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of potassium on blood pressure in DOCA salt hypertension in rats.
    Suzuki H; Kondo K; Saruta T
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):525-32. PubMed ID: 7270008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypotensive responses to centrally administered taurine in DOCA-salt hypertensive and spontaneously hypertensive rats.
    Inoue A; Takahashi H; Lee LC; Sasaki S; Takeda K; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Circ J; 1986 Dec; 50(12):1215-23. PubMed ID: 3820530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis.
    Komeichi H; Moreau R; Cailmail S; Gaudin C; Lebrec D
    J Hepatol; 1995 Mar; 22(3):319-25. PubMed ID: 7608483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
    Fujita K; Matsumura Y; Kita S; Miyazaki Y; Hisaki K; Takaoka M; Morimoto S
    Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of sympathetic nerve activity and natriuresis in the antihypertensive actions of potassium in NaCl hypertension.
    Fujita T; Sato Y; Ando K
    Jpn Circ J; 1983 Oct; 47(10):1227-31. PubMed ID: 6632175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pressure natriuresis in salt-sensitive and salt-resistant Sabra rats.
    Gross V; Lippoldt A; Yagil C; Yagil Y; Luft FC
    Hypertension; 1997 Jun; 29(6):1252-9. PubMed ID: 9180625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of K+-canrenoate on the development of DOCA-salt hypertension.
    Vargas F; Haro JM; Jodar E; Soler A; Garcia del Rio C
    J Pharm Pharmacol; 1989 May; 41(5):335-8. PubMed ID: 2569521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of norepinephrine release from vascular adrenergic neurons by oral administration of beta-blocker in DOCA-salt hypertension.
    Tsuda K; Masuyama Y
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):68-71. PubMed ID: 2007000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phasic plasma atrial natriuretic polypeptide changes in DOCA-salt hypertensive rats.
    Sato Y; Ito Y; Ando K; Ogata E; Fujita T
    Jpn Heart J; 1990 Sep; 31(5):703-11. PubMed ID: 2148777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased cardiovascular responsiveness to GABAergic stimulation in DOCA-salt hypertensive rats.
    Magrì V; Trimarchi GR; Quattrone G; Squadrito F; Di Giorgio RM; Costa G; Caputi AP
    Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):107-18. PubMed ID: 6433410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High potassium intake attenuates antinatriuretic response to air stress in DOCA-salt rats.
    Sato Y; Ando K; Ogata E; Fujita T
    Am J Physiol; 1991 May; 260(5 Pt 2):R941-5. PubMed ID: 2035706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased plasma levels and effects of brain natriuretic peptide in experimental nephrosis.
    Yokota N; Yamamoto Y; Iemura F; Kita T; Kangawa K; Minamino N; Matsuo H; Eto T
    Nephron; 1993; 65(3):454-9. PubMed ID: 8289999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.